Global Translational Regenerative Medicine Market Worth $14.5bn in 2021

Thursday 1 June 2017, Amsterdam

This new report, now available on ASDReports, Global Translational Regenerative Medicine Market Prospects 2017-2027: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies indicates that the Global Translational Regenerative Medicine Market will see $14.5bn in spending in 2021.

The Global Translational Regenerative Medicine market is expected to grow significantly over the forecast period. The Global Translational Regenerative Medicine market was valued at $5.8bn in 2016. The key player forecasts this market to increase to $14.5bn in 2021. The market is estimated to grow at a CAGR of 19.9% in the first half of the forecast period and 17.7% from 2016 to 2027.

The lead analyst of the report said: “Growth in the global TRM market will be fuelled particularly by stem cell therapies and tissue engineering advancements, as well as the emergence of commercial gene therapy products. The improvements in regulation of stem cell research on a regional level will increase its attractiveness. We note that advancements such as 3D bioprinting should enable the development of tissues which can be used for toxicology testing purposes.

Furthermore, strong government support for regenerative medicine particularly in countries such as China and South Korea, as well as the accelerated regulatory pathway for regenerative medicine in Japan will fuel growth in stem cell therapies.”

The 316-page report contains 107 tables and 66 figures that add visual analysis in order to explain the developing trends within the Global Translational Regenerative Medicine Market.

The key player provides revenue forecasts for the period 2017-2027 for the global market as well as the leading submarkets: Stem Cell Therapies, Tissue Engineered Products and Gene Therapies.